0
ARTICLE |

HEXAMETHYLENAMIN : THE LIBERATION OF FORMALDEHYD AND THE ANTISEPTIC EFFICIENCY UNDER DIFFERENT CHEMICAL AND BIOLOGICAL CONDITIONS

PAUL J. HANZLIK, M.D.; R. J. COLLINS, A.B.
Arch Intern Med (Chic). 1913;XII(5):578-612. doi:10.1001/archinte.1913.00070050095009.
Text Size: A A A
Published online

Ever since the recognition of hexamethylenamin as a beneficial therapeutic agent in vesical conditions by Nicolaier1 in 1894, the use of this drug has steadily increased. It has been recommended as an antiseptic agent for practically all of the body fluids, largely on the basis of the fact that after internal administration it has been found present everywhere in the body. Although it has been quite generally recognized that hexamethylenamin is practically non-toxic, the criteria for its action as an antiseptic have only comparatively recently begun to be appreciated. Its decomposition into ammonia and formaldehyd is well known, and it is generally believed by pharmacologists that the bactericidal properties of hexamethylenamin are due to the liberated formaldehyd. However, there has been no absolute proof that free hexamethylenamin may not prevent bacterial growth. Indeed, it is maintained by some clinicians that hexamethylenamin is bactericidal and that the presence of

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();